These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 8473726)
1. Class II-restricted presentation of a hen egg lysozyme determinant derived from endogenous antigen sequestered in the cytoplasm or endoplasmic reticulum of the antigen presenting cells. Brooks AG; McCluskey J J Immunol; 1993 May; 150(9):3690-7. PubMed ID: 8473726 [TBL] [Abstract][Full Text] [Related]
2. Processing of endogenously synthesized hen egg-white lysozyme retained in the endoplasmic reticulum or in secretory form gives rise to a similar but not identical set of epitopes recognized by class II-restricted T cells. Adorini L; Guéry JC; Fuchs S; Ortiz-Navarrete V; Hämmerling GJ; Momburg F J Immunol; 1993 Oct; 151(7):3576-86. PubMed ID: 7690807 [TBL] [Abstract][Full Text] [Related]
3. Cytosolic targeting of hen egg lysozyme gives rise to a short-lived protein presented by class I but not class II major histocompatibility complex molecules. Calin-Laurens V; Forquet F; Mottez E; Kanellopoulos J; Godeau F; Kourilsky P; Gerlier D; Rabourdin-Combe C Eur J Immunol; 1991 Mar; 21(3):761-9. PubMed ID: 2009914 [TBL] [Abstract][Full Text] [Related]
4. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell. Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420 [TBL] [Abstract][Full Text] [Related]
5. Major histocompatibility complex class II-restricted presentation of secreted and endoplasmic reticulum resident antigens requires the invariant chains and is sensitive to lysosomotropic agents. Humbert M; Bertolino P; Forquet F; Rabourdin-Combe C; Gerlier D; Davoust J; Salamero J Eur J Immunol; 1993 Dec; 23(12):3167-72. PubMed ID: 8258331 [TBL] [Abstract][Full Text] [Related]
6. Anergic B cells constitutively present self antigen: enhanced immunoglobulin receptor-mediated presentation of antigenic determinants by B cells is hierarchical. Kanost D; McCluskey J Eur J Immunol; 1994 May; 24(5):1186-93. PubMed ID: 7514133 [TBL] [Abstract][Full Text] [Related]
7. Class II-restricted presentation of an endogenously derived immunodominant T-cell determinant of hen egg lysozyme. Brooks A; Hartley S; Kjer-Nielsen L; Perera J; Goodnow CC; Basten A; McCluskey J Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3290-4. PubMed ID: 1707537 [TBL] [Abstract][Full Text] [Related]
8. Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen. Moreno J; Vignali DA; Nadimi F; Fuchs S; Adorini L; Hämmerling GJ J Immunol; 1991 Nov; 147(10):3306-13. PubMed ID: 1658143 [TBL] [Abstract][Full Text] [Related]
9. The extracellular domains of MHC class II molecules determine their processing requirements for antigen presentation. Kjer-Nielsen L; Perera JD; Boyd LF; Margulies DH; McCluskey J J Immunol; 1990 Apr; 144(8):2915-24. PubMed ID: 1969876 [TBL] [Abstract][Full Text] [Related]
10. Antigen presentation of hen egg-white lysozyme but not of ribonuclease A is augmented by the major histocompatibility complex class II-associated invariant chain. Nadimi F; Moreno J; Momburg F; Heuser A; Fuchs S; Adorini L; Hämmerling GJ Eur J Immunol; 1991 May; 21(5):1255-63. PubMed ID: 2037011 [TBL] [Abstract][Full Text] [Related]
11. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells. Snider DP; Segal DM J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743 [TBL] [Abstract][Full Text] [Related]
12. Invariant chain expression similarly controls presentation of endogenously synthesized and exogenous antigens by MHC class II molecules. Lombard-Platet S; Bertolino P; Gimenez C; Humbert M; Gerlier D; Rabourdin-Combe C Cell Immunol; 1993 Apr; 148(1):60-70. PubMed ID: 8495491 [TBL] [Abstract][Full Text] [Related]
13. Presentation on class II MHC molecules of endogenous lysozyme targeted to the endocytic pathway. Parra-López CA; Lindner R; Vidavsky I; Gross M; Unanue ER J Immunol; 1997 Mar; 158(6):2670-9. PubMed ID: 9058800 [TBL] [Abstract][Full Text] [Related]
14. I-Ak polymorphisms define a functionally dominant region for the presentation of hen egg lysozyme peptides. Rosloniec EF; Vitez LJ; Beck BN; Buerstedde JM; McKean DJ; Landais D; Benoist C; Mathis D; Freed JH J Immunol; 1989 Jul; 143(1):50-8. PubMed ID: 2786533 [TBL] [Abstract][Full Text] [Related]
15. Threshold detection of self-antigen/MHC class II complexes formed in vivo: constitutive presentation of an immunodominant epitope of hen egg lysozyme (HEL) in HEL-transgenic mice. Kanost D; Basten A; McCluskey J Int Immunol; 1993 Aug; 5(8):893-902. PubMed ID: 8398984 [TBL] [Abstract][Full Text] [Related]
16. Distinct effects of recombinant cholera toxin B subunit and holotoxin on different stages of class II MHC antigen processing and presentation by macrophages. Matousek MP; Nedrud JG; Harding CV J Immunol; 1996 Jun; 156(11):4137-45. PubMed ID: 8666780 [TBL] [Abstract][Full Text] [Related]
18. Cell type-specific processing of the I-Ed-restricted hen egg lysozyme determinant 107-116. Robadey C; Wallny HJ; Demotz S Eur J Immunol; 1996 Jul; 26(7):1656-9. PubMed ID: 8766576 [TBL] [Abstract][Full Text] [Related]
19. Antigen presentation by dendritic cells focuses T cell responses against immunodominant peptides: studies in the hen egg-white lysozyme (HEL) model. Gapin L; Bravo de Alba Y; Casrouge A; Cabaniols JP; Kourilsky P; Kanellopoulos J J Immunol; 1998 Feb; 160(4):1555-64. PubMed ID: 9469410 [TBL] [Abstract][Full Text] [Related]
20. Recombinant Escherichia coli express a defined, cytoplasmic epitope that is efficiently processed in macrophage phagolysosomes for class II MHC presentation to T lymphocytes. Pfeifer JD; Wick MJ; Russell DG; Normark SJ; Harding CV J Immunol; 1992 Oct; 149(8):2576-84. PubMed ID: 1383320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]